Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

Clinical application of cancer immunotherapy requires a better understanding of tumor immunogenicity and the tumor microenvironment. HLA class I molecules present antigens to CD8+ cytotoxic cells. Their loss or downregulation is frequently found in tumors resulting in reduced T cell responses and wo...

Full description

Saved in:
Bibliographic Details
Main Authors: Sinn, Bruno (Author) , Weber, Karsten E. (Author) , Schmitt, Wolfgang Daniel (Author) , Fasching, Peter Andreas (Author) , Symmans, William Fraser (Author) , Blohmer, Jens-Uwe (Author) , Karn, Thomas (Author) , Taube, Eliane Tabea (Author) , Klauschen, Frederick (Author) , Marmé, Frederik (Author) , Schem, Christian (Author) , Stickeler, Elmar (Author) , Ataseven, Beyhan (Author) , Huober, Jens (Author) , Minckwitz, Gunter von (Author) , Seliger, Barbara (Author) , Denkert, Carsten (Author) , Loibl, Sibylle (Author)
Format: Article (Journal)
Language:English
Published: 11 December 2019
In: Breast cancer research
Year: 2019, Volume: 21, Pages: 1-9
ISSN:1465-542X
DOI:10.1186/s13058-019-1231-z
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13058-019-1231-z
Get full text
Author Notes:Bruno Valentin Sinn, Karsten E. Weber, Wolfgang Daniel Schmitt, Peter A. Fasching, William Fraser Symmans, Jens-Uwe Blohmer, Thomas Karn, Eliane Tabea Taube, Frederick Klauschen, Frederik Marmé, Christian Schem, Elmar Stickeler, Beyhan Ataseven, Jens Huober, Gunter von Minckwitz, Barbara Seliger, Carsten Denkert, and Sibylle Loibl

MARC

LEADER 00000caa a2200000 c 4500
001 1698606540
003 DE-627
005 20220822105533.0
007 cr uuu---uuuuu
008 200520s2019 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13058-019-1231-z  |2 doi 
035 |a (DE-627)1698606540 
035 |a (DE-599)KXP1698606540 
035 |a (OCoLC)1341325906 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sinn, Bruno  |e VerfasserIn  |0 (DE-588)107988131X  |0 (DE-627)842397167  |0 (DE-576)453064752  |4 aut 
245 1 0 |a Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer  |b association with response and survival after neoadjuvant chemotherapy  |c Bruno Valentin Sinn, Karsten E. Weber, Wolfgang Daniel Schmitt, Peter A. Fasching, William Fraser Symmans, Jens-Uwe Blohmer, Thomas Karn, Eliane Tabea Taube, Frederick Klauschen, Frederik Marmé, Christian Schem, Elmar Stickeler, Beyhan Ataseven, Jens Huober, Gunter von Minckwitz, Barbara Seliger, Carsten Denkert, and Sibylle Loibl 
264 1 |c 11 December 2019 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.05.2020 
520 |a Clinical application of cancer immunotherapy requires a better understanding of tumor immunogenicity and the tumor microenvironment. HLA class I molecules present antigens to CD8+ cytotoxic cells. Their loss or downregulation is frequently found in tumors resulting in reduced T cell responses and worse prognosis. 
540 |q DE-3  |a Namensnennung 4.0 International  |f CC BY 4.0  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
700 1 |a Weber, Karsten E.  |e VerfasserIn  |4 aut 
700 1 |a Schmitt, Wolfgang Daniel  |d 1975-  |e VerfasserIn  |0 (DE-588)129977527  |0 (DE-627)485303302  |0 (DE-576)297931547  |4 aut 
700 1 |a Fasching, Peter Andreas  |d 1975-  |e VerfasserIn  |0 (DE-588)129068780  |0 (DE-627)388703040  |0 (DE-576)297477099  |4 aut 
700 1 |a Symmans, William Fraser  |e VerfasserIn  |4 aut 
700 1 |a Blohmer, Jens-Uwe  |d 1962-  |e VerfasserIn  |0 (DE-588)122376641  |0 (DE-627)081907958  |0 (DE-576)293244227  |4 aut 
700 1 |a Karn, Thomas  |d 1964-  |e VerfasserIn  |0 (DE-588)118155822  |0 (DE-627)694720925  |0 (DE-576)291743412  |4 aut 
700 1 |a Taube, Eliane Tabea  |e VerfasserIn  |4 aut 
700 1 |a Klauschen, Frederick  |d 1974-  |e VerfasserIn  |0 (DE-588)129955779  |0 (DE-627)484980890  |0 (DE-576)297920766  |4 aut 
700 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
700 1 |a Schem, Christian  |d 1974-  |e VerfasserIn  |0 (DE-588)124076661  |0 (DE-627)085621986  |0 (DE-576)294009183  |4 aut 
700 1 |a Stickeler, Elmar  |d 1965-  |e VerfasserIn  |0 (DE-588)1110784147  |0 (DE-627)86516584X  |0 (DE-576)475779843  |4 aut 
700 1 |a Ataseven, Beyhan  |d 1973-  |e VerfasserIn  |0 (DE-588)121880885  |0 (DE-627)081595190  |0 (DE-576)292934726  |4 aut 
700 1 |a Huober, Jens  |e VerfasserIn  |0 (DE-588)1059154676  |0 (DE-627)798048239  |0 (DE-576)415183898  |4 aut 
700 1 |a Minckwitz, Gunter von  |d 1964-  |e VerfasserIn  |0 (DE-588)172260035  |0 (DE-627)673296962  |0 (DE-576)133128202  |4 aut 
700 1 |a Seliger, Barbara  |e VerfasserIn  |0 (DE-588)1158161409  |0 (DE-627)1021862673  |0 (DE-576)503672858  |4 aut 
700 1 |a Denkert, Carsten  |d 1969-  |e VerfasserIn  |0 (DE-588)118129929  |0 (DE-627)079261124  |0 (DE-576)291730604  |4 aut 
700 1 |a Loibl, Sibylle  |e VerfasserIn  |0 (DE-588)12433024X  |0 (DE-627)085790508  |0 (DE-576)294122753  |4 aut 
773 0 8 |i Enthalten in  |t Breast cancer research  |d London : BioMed Central, 1999  |g 21(2019), Artikel-ID 142, Seite 1-9  |h Online-Ressource  |w (DE-627)326645950  |w (DE-600)2041618-0  |w (DE-576)27922463X  |x 1465-542X  |7 nnas  |a Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer association with response and survival after neoadjuvant chemotherapy 
773 1 8 |g volume:21  |g year:2019  |g elocationid:142  |g pages:1-9  |g extent:9  |a Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer association with response and survival after neoadjuvant chemotherapy 
856 4 0 |u https://doi.org/10.1186/s13058-019-1231-z  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20200520 
993 |a Article 
994 |a 2019 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 910000  |d 910400  |d 60000  |d 61300  |d 50000  |e 910000PM132561972  |e 910400PM132561972  |e 60000PM132561972  |e 61300PM132561972  |e 50000PM132561972  |k 0/910000/  |k 1/910000/910400/  |k 0/60000/  |k 1/60000/61300/  |k 0/50000/  |p 10 
999 |a KXP-PPN1698606540  |e 3668765928 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Bruno Valentin Sinn, Karsten E. Weber, Wolfgang Daniel Schmitt, Peter A. Fasching, William Fraser Symmans, Jens-Uwe Blohmer, Thomas Karn, Eliane Tabea Taube, Frederick Klauschen, Frederik Marmé, Christian Schem, Elmar Stickeler, Beyhan Ataseven, Jens Huober, Gunter von Minckwitz, Barbara Seliger, Carsten Denkert, and Sibylle Loibl"]},"physDesc":[{"extent":"9 S."}],"recId":"1698606540","relHost":[{"id":{"zdb":["2041618-0"],"eki":["326645950"],"issn":["1465-542X"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"326645950","pubHistory":["1.1999 -"],"part":{"year":"2019","pages":"1-9","text":"21(2019), Artikel-ID 142, Seite 1-9","extent":"9","volume":"21"},"title":[{"title_sort":"Breast cancer research","title":"Breast cancer research"}],"note":["Gesehen am 29.12.2016"],"origin":[{"publisherPlace":"London","dateIssuedDisp":"1999-","publisher":"BioMed Central","dateIssuedKey":"1999"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"disp":"Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer association with response and survival after neoadjuvant chemotherapyBreast cancer research"}],"id":{"doi":["10.1186/s13058-019-1231-z"],"eki":["1698606540"]},"person":[{"given":"Bruno","role":"aut","family":"Sinn","display":"Sinn, Bruno"},{"given":"Karsten E.","role":"aut","display":"Weber, Karsten E.","family":"Weber"},{"family":"Schmitt","display":"Schmitt, Wolfgang Daniel","given":"Wolfgang Daniel","role":"aut"},{"role":"aut","given":"Peter Andreas","family":"Fasching","display":"Fasching, Peter Andreas"},{"display":"Symmans, William Fraser","family":"Symmans","role":"aut","given":"William Fraser"},{"given":"Jens-Uwe","role":"aut","display":"Blohmer, Jens-Uwe","family":"Blohmer"},{"family":"Karn","display":"Karn, Thomas","given":"Thomas","role":"aut"},{"role":"aut","given":"Eliane Tabea","display":"Taube, Eliane Tabea","family":"Taube"},{"given":"Frederick","role":"aut","family":"Klauschen","display":"Klauschen, Frederick"},{"display":"Marmé, Frederik","family":"Marmé","role":"aut","given":"Frederik"},{"given":"Christian","role":"aut","display":"Schem, Christian","family":"Schem"},{"display":"Stickeler, Elmar","family":"Stickeler","given":"Elmar","role":"aut"},{"given":"Beyhan","role":"aut","display":"Ataseven, Beyhan","family":"Ataseven"},{"given":"Jens","role":"aut","family":"Huober","display":"Huober, Jens"},{"family":"Minckwitz","display":"Minckwitz, Gunter von","given":"Gunter von","role":"aut"},{"display":"Seliger, Barbara","family":"Seliger","given":"Barbara","role":"aut"},{"given":"Carsten","role":"aut","display":"Denkert, Carsten","family":"Denkert"},{"family":"Loibl","display":"Loibl, Sibylle","given":"Sibylle","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 20.05.2020"],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"11 December 2019"}],"title":[{"title":"Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer","subtitle":"association with response and survival after neoadjuvant chemotherapy","title_sort":"Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer"}],"language":["eng"]} 
SRT |a SINNBRUNOWHUMANLEUCO1120